Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography

Atherosclerosis

Volumn 225, Issue 2, 2012, Pages 456-460

  Arbel, Yaron ^a,b   Finkelstein, Ariel ^a,b   Halkin, Amir ^a,b   Birati, Edo Y ^a,b   Revivo, Miri ^a,b   Zuzut, Meital ^a,b   Shevach, Ayala ^a,b   Berliner, Shlomo ^a   Herz, Itzhak ^a,b   Keren, Gad ^a,b   Banai, Shmuel ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Coronary artery disease; MACE; Neutrophil lymphocyte ratio; White blood cell

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD CELL COUNT; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIET THERAPY; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HAZARD RATIO; HEART CATHETERIZATION; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN TREATMENT; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LYMPHOCYTE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NEUTROPHIL; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; OUTCOME ASSESSMENT; PATIENT REFERRAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE CORONARY SYNDROME; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; ISRAEL; LOGISTIC MODELS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEUTROPHILS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; YOUNG ADULT;

EID: 84869496548     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.09.009     Document Type: Article

References (28)

1. Margolis K.L., Manson J.E., Greenland P., et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the women's health initiative observational study. Arch Intern Med 2005, 165:500-508.
2. Furman M.I., Gore J.M., Anderson F.A., et al. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Am Heart J 2004, 147:42-48.
3. Horne B.D., Anderson J.L., John J.M., et al. Which white blood cell subtypes predict increased cardiovascular risk?. J Am Coll Cardiol 2005, 45:1638-1643.
4. Widmer A., Linka A.Z., Attenhofer Jost C.H., et al. Mechanical complications after myocardial infarction reliably predicted using C-reactive protein levels and lymphocytopenia. Cardiology 2003, 99:25-31.
5. Cho K.H., Jeong M.H., Ahmed K., et al. Value of early risk stratification using hemoglobin level and neutrophil-to-lymphocyte ratio in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2011, 107:849-856.
6. Duffy B.K., Gurm H.S., Rajagopal V., et al. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol 2006, 97:993-996.
7. Nunez J., Nunez E., Bodi V., et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol 2008, 101:747-752.
8. Poludasu S., Cavusoglu E., Khan W., et al. Neutrophil to lymphocyte ratio as a predictor of long-term mortality in African Americans undergoing percutaneous coronary intervention. Clin Cardiol 2009, 32:E6-E10.
9. Bhutta H., Agha R., Wong J., et al. Neutrophil-lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross-sectional study. Vasc Endovascular Surg 2011, 45:227-231.
10. Uthamalingam S., Patvardhan E.A., Subramanian S., et al. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol 2011, 107:433-438.
11. Azab B., Zaher M., Weiserbs K.F., et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 2010, 106:470-476.
12. Sabatine M.S., Morrow D.A., Cannon C.P., et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (treat angina with aggrastat and determine cost of therapy with an invasive or conservative strategy - thrombolysis in myocardial infarction 18 trial) substudy. J Am Coll Cardiol 2002, 40:1761-1768.
13. Steinvil A., Sadeh B., Arbel Y., et al. Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease. J Am Coll Cardiol 2011, 57:779-783.
14. Arbel Y., Eros Y., Rogowski O., et al. Comparison of values of wide-range C-reactive protein to high-sensitivity C-reactive protein in patients undergoing coronary angiography. Am J Cardiol 2007, 99:1504-1506.
15. Arbel Y., Banai S., Benhorin J., et al. Erythrocyte aggregation as a cause of slow flow in patients of acute coronary syndromes. Int J Cardiol 2011.
16. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non-st-elevation myocardial infarction): developed in collaboration with the American college of emergency physicians, the society for cardiovascular angiography and interventions, and the society of thoracic surgeons: endorsed by the American association of cardiovascular and pulmonary rehabilitation and the society for academic emergency medicine. Circulation, 2007;116:e148-304.
17. Rogowski O., Vered Y., Shapira I., et al. Introducing the wide range C-reactive protein (wr-CRP) into clinical use for the detection of microinflammation. Clin Chim Acta 2005, 358:151.
18. Libby P., Ridker P.M. Inflammation and atherothrombosis from population biology and bench research to clinical practice. J Am Coll Cardiol 2006, 48:A33-A46.
19. Ridker P.M., Danielson E., Fonseca F.A., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008, 359:2195-2207.
20. Nelson D.H., Sandberg A.A., Palmer J.G., et al. Blood levels of 17-hydroxycorticosteroids following the administration of adrenal steroids and their relation to levels of circulating leukocytes. J Clin Invest 1952, 31:843-849.
21. Blum A., Sclarovsky S., Rehavia E., et al. Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction. Am Heart J 1994, 127:1226-1230.
22. Arruda-Olson A.M., Reeder G.S., Bell M.R., et al. Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study. Circ Cardiovasc Qual Outcomes 2009, 2:656-662.
23. Baldus S., Heeschen C., Meinertz T., et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003, 108:1440-1445.
24. Azab B., Daoud J., Naeem F.B., et al. Neutrophil-to-lymphocyte ratio as a predictor of worsening renal function in diabetic patients (3-year follow-up study). Ren Fail 2012, 34:571-576.
25. Park B.J., Shim J.Y., Lee H.R., et al. Relationship of neutrophil-lymphocyte ratio with arterial stiffness and coronary calcium score. Clin Chim Acta 2011, 412:925-929.
26. Akpek M., Kaya M.G., Lam Y.Y., et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with st-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012.
27. Wang R., Chen P.J., Chen W.H. Diet and exercise improve neutrophil to lymphocyte ratio in overweight adolescents. Int J Sports Med 2011.
28. Dutta P., Courties G., Wei Y., et al. Myocardial infarction accelerates atherosclerosis. Nature 2012, 487:325-329.